Open AccessEribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study
Author(s) -
Rebecca Pedersini,
L. Vassalli,
Mélanie Claps,
Antonella Tulla,
Filippo Rodella,
Salvatore Grisanti,
Vito Amoroso,
Elisa Roca,
Edda Simoncini,
Alfredo Berruti
Publication year - 2018
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000489063
Subject(s) - eribulin , tolerability , medicine , metastatic breast cancer , breast cancer , retrospective cohort study , oncology , progression free survival , surgery , cancer , adverse effect , overall survival
The aim of this study was to investigate efficacy and safety of eribulin in heavily pretreated patients with advanced breast cancer (BC) in a real-life setting.